Factors influencing breast cancer outcomes in Australia: A systematic review

Eur J Cancer Care (Engl). 2019 Jul;28(4):e13038. doi: 10.1111/ecc.13038. Epub 2019 Mar 27.

Abstract

Purpose: This systematic review evaluates factors influencing breast cancer outcomes for women treated in Australia, facilitating the exploration of disparities in breast cancer outcomes for certain groups of women in Australia.

Method: A systematic literature search was performed using MEDLINE and Scopus focusing on breast cancer in Australia with outcome measures being breast cancer survival and recurrence with no restrictions on date. Risk of bias was assessed using Cairns Assessment Scale for Observational studies of Risk factors (CASOR).

Results: Fifteen quantitative studies were included: two were high quality, 11 were intermediate quality, and two were low quality. Traditional risk factors such as invasive tumour type, larger size, higher grade and stage, lymph node involvement and absence of hormone receptors were found to be associated with breast cancer mortality. Being younger (<40 years old) and older (>70 years old), having more comorbidities, being of lower socioeconomic status, identifying as Aboriginal or Torres Strait Islander, living in more rural areas or having a mastectomy were factors found to be associated with poorer breast cancer outcomes.

Conclusion: Despite the heterogeneity of the studies, this review identified significant risk factors for breast cancer mortality and recurrence. The use of this data would be most useful in developing evidence-based interventions and in optimising patient care through creation of a prediction model.

Prospero registration: CRD42017072857.

Keywords: Australia; breast neoplasms; mortality; prognosis; recurrence; risk factors.

Publication types

  • Systematic Review

MeSH terms

  • Age Factors
  • Antineoplastic Agents / therapeutic use*
  • Australia
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Comorbidity
  • Female
  • Humans
  • Lymph Nodes / pathology
  • Mastectomy*
  • Native Hawaiian or Other Pacific Islander
  • Neoplasm Metastasis
  • Prognosis
  • Radiotherapy*
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone / metabolism
  • Risk Factors
  • Rural Population
  • Social Class
  • Tumor Burden

Substances

  • Antineoplastic Agents
  • Receptors, Estrogen
  • Receptors, Progesterone